{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T19:10:09Z","timestamp":1758568209228,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.therap.2022.06.002","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T21:36:44Z","timestamp":1656538604000},"page":"330-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00c9ryth\u00e8me noueux associ\u00e9 au vaccin Tozinam\u00e9ran\u00a0: \u00e0 propos de 2\u00a0cas et revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"78","author":[{"given":"Khouloud","family":"Berrim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rym","family":"Sahnoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ksentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Athyemen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamilia","family":"Ksouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanen","family":"Affes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serria","family":"Hammemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Zeghal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna","family":"Ben Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2022.06.002_bib0055","doi-asserted-by":"crossref","first-page":"A82","DOI":"10.1016\/j.revmed.2015.03.032","article-title":"\u00c9ryth\u00e8me noueux\u00a0: \u00e0 propos de 95\u00a0cas","volume":"36","author":"Loubiri","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.therap.2022.06.002_bib0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.therap.2022.03.001","article-title":"Pharmacovigilance and drug safety: Fair prescribing and clinical research","volume":"77","author":"Montastruc","year":"2022","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.06.002_bib0065","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1111\/dth.15410","article-title":"Covid-19\u00a0vaccine associated erythema nodosum: Factors to consider","volume":"35","author":"Damevska","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.therap.2022.06.002_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4236\/wjv.2021.113005","article-title":"Erythema nodosum manifestation post COVID-19\u00a0vaccine: a case report","volume":"11","author":"Hali","year":"2021","journal-title":"World J Vaccines"},{"key":"10.1016\/j.therap.2022.06.002_bib0075","first-page":"15302","article-title":"Erythema nodosum after Moderna mRNA-1273\u00a0Covid-19\u00a0vaccine","volume":"4","author":"Teymour","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.therap.2022.06.002_bib0080","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/jdv.17678","article-title":"Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19\u00a0vaccine: report of three cases from India","volume":"36","author":"Mehta","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.therap.2022.06.002_bib0085","first-page":"e19529","article-title":"First case of erythema nodosum associated with Pfizer vaccine","volume":"13","author":"Aly","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.therap.2022.06.002_bib0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jdin.2021.12.009","article-title":"Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2\u00a0COVID-19\u00a0messenger RNA vaccine","volume":"6","author":"Wu","year":"2022","journal-title":"JAAD Int"},{"key":"10.1016\/j.therap.2022.06.002_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jdv.17762","article-title":"Erythema nodosum following the first dose of ChAdOx1-S nCoV-19\u00a0vaccine","volume":"36","author":"Cameli","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.therap.2022.06.002_bib0050","article-title":"Erythema nodosum induced by Covid-19\u00a0Pfizer-BioNTech mRNA vaccine","author":"Chahed","year":"2022","journal-title":"Br J Clin Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572200107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572200107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:56:20Z","timestamp":1758567380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059572200107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S004059572200107X"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2022.06.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9ryth\u00e8me noueux associ\u00e9 au vaccin Tozinam\u00e9ran\u00a0: \u00e0 propos de 2\u00a0cas et revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2022.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}